Federal Register / Vol. 71, No. 240 / Thursday, December 14, 2006 / Notices 75263 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Initial 

Review Group, Clinical and Treatment 

Subcommittee. 

Date: March 1–2, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Double Tree Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Katrina L. Foster, PhD., 

Scientific Review Administrator, National 

Institute on Alcohol Abuse & Alcoholism, 

National Institutes of Health, 5635 Fishers 

Lane, Rm. 3042, Rockville, MD 20852, 301–

443–4032. katrina@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants, 

National Institutes of Health, HHS) 

Dated: December 7, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9707 Filed 12–13–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Advisory council for 

Biomedical Imaging and Bioengineering. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the contact Person listed below in 

advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council for Biomedical Imaging and 

Bioengineering, January 26, 2007 Council 

Meeting. 

Date: January 26, 2007. 

Open: 8:45 a.m. to 12:15 p.m. 

Agenda: Report from the Institute Director, 

other Institute Staff and presentations of 

working group reports. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Closed: 1:15 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suite, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Anthony Demsey, PhD, 

Director, Office of Extramural Policy, 

National Institute of Biomedical Imaging and 

Bioengineering, 6701 Democracy Blvd., 

Room 241, Bethesda, MD 20892. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business of professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nibib1.nih.gov/about/NACBIB/ 

NACBIB.htm, where an agenda and any 

additional information for the meeting will 

be posted when available. 

Dated: December 7, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9708 Filed 12–13–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, State 

and Local Epidemiology Planning and 

Information Development. 

Date: January 24–25, 2007. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Courtyard by Marriott Rockville, 

2500 Research Boulevard, Rockville, MD 

20850. 

Contact Person: Lyle Furr, Contract Review 

Specialist, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1439, lf33c.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, 

Development of Science Literacy Materials or 

Programs. 

Date: February 7, 2007. 

Time: 9 a.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Courtyard by Marriott Rockville, 

2500 Research Boulevard, Rockville, MD 

20850. 

Contact Person: Lyle Furr, Contract Review 

Specialist, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1439, lf33c.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, 

Mechanisms and Methods to Maximize Data 

Utilization. 

Date: February 21, 2007. 

Time: 9 a.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Courtyard by Marriott Rockville, 

2500 Research Boulevard, Rockville, MD 

20850. 

Contact Person: Lyle Furr, Contract Review 

Specialist, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1439, if33c.nih.gov. 

Name of Committee: National Institue on 

Drug Abuse Special Emphasis Panel, 

Development of Practical Training Materials 

for Evidence-Based Treatment. 

Date: March 13, 2007. 

Time: 9 a.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Courtyard by Marriott Rockville, 

2500 Research Boulevard, Rockville, MD 

20850. 

Contact Person: Lyle Furr, Contract Review 

Specialist, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1439, if33c.nih.gov. 


rwilkins on PROD1PC63 with NOTICES